This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Academia Sinica, Evolutive Labs Co., Ltd.. Active years: 2016-2026.
Company Filing History:
Years Active: 2016-2026
Title: Innovations of Wei-Chun Liu
Introduction
Wei-Chun Liu is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of hybrid glucanases. His work has implications for various applications in research and industry.
Latest Patents
Wei-Chun Liu holds a patent for a dual-functional hybrid glucanase. This invention describes a fusion polypeptide that includes a first segment containing a 1,3-1,4-β-D-glucanase (Fsβ-glucanase) or a fragment thereof. Additionally, it features a second segment containing a first 1,3-β-D-glucanase (TmLam) or a fragment thereof. An optional third segment may also be included, which contains a second 1,3-β-D-glucanase (TmLam) or a fragment thereof. The fusion polypeptide exhibits glucanase activity, and the patent also covers a nucleic acid molecule encoding the fusion polypeptide and methods for its use. Wei-Chun Liu has 1 patent to his name.
Career Highlights
Wei-Chun Liu is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at this institution has allowed him to engage in cutting-edge research and contribute to advancements in biotechnology.
Collaborations
One of his notable collaborators is Lie-Fen Shyur, with whom he has worked on various research projects. Their collaboration has furthered the understanding and application of glucanases in scientific research.
Conclusion
Wei-Chun Liu's innovative work in the field of hybrid glucanases showcases his expertise and dedication to advancing biotechnology. His contributions are valuable to both academic research and practical applications in the industry.